The rs1056948 single nucleotide polymorphisms (SNP) in the 3′ UTR of ZNF217 (with a putative function in inactivating exonic splicing enhancer sequences) and the rs61730988 SNP (responsible for the E914D mutation) are associated with breast cancer susceptibility [93, 94]. Here, ZNF217 is linked to breast carcinoma.